Events

The Future of Science: How Women are Leading Medical Innovation

From 1990 to 2016, the share of women in the life sciences industry increased from 34 to 47 percent. Women also make up more than half of Ph.Ds. in biological and agricultural sciences. And many researchers are working to address health issues affecting women, ranging from endometriosis to heart conditions. Industry leaders, policymakers and academics have also shown how they’re dedicated to continuing to support innovation — and this includes fostering the next generation of scientists.

Forbes Healthcare Summit

Medicine is improving at a breakneck pace; breakthroughs such as immunotherapy and genetics are changing the way we treat cancer. New drugs are being approved at an unprecedented rate while artificial intelligence and deep learning, until recently just science fiction, are actually starting to make a real difference in public health. The big question now: how can we take this kindling and set it ablaze?

People v. Cancer

Cancer isn’t as lethal as it once was, and yet more than 600,000 Americans are estimated to die from it this year alone, making this complex set of diseases the second leading cause of death in the country. But hope is rising: big data, immuno-oncology and once-in-a-generation medical advances have led to dramatic breakthroughs. New insights into the disease have pushed boundaries, with patients receiving uniquely personalized care.

Leading on Value: Solutions for an Evolving Health Care System

How can Washington and the private sector work together to manage the cost of health care and deliver value to consumers? The two-part event will feature health care industry CEOs discussing the evolution of the pharmaceutical business model and a reevaluation of priorities including production of personalized medicines, R&D, and care for chronic diseases.

Turning Point: Documentary Screening + Conversation

An estimated 5.7 million people in this country have Alzheimer’s. And the search for a treatment or a cure has not been promising. In the documentary, Turning Point, filmmaker James Keach, follows a team of scientists on the front lines of Alzheimer’s research and captures the disappointment and renewed hope of those working to disrupt the disease.

The State of Care: Disrupting Alzheimer's

The history of Alzheimer’s research has been filled with setback after setback – in fact nearly every clinical trial has failed – but it is also one marked by perseverance and renewed hope. Advancements in medical imaging have increased our understanding of how the disease strikes, and efforts are underway to develop diagnostics to treat the disease before its onset.

The State of Care: Innovation & Access

America is a laboratory for ideas – a testing ground to advance human thought and potential from which entire industries have been born – from media and entertainment, to tech giants capitalizing on the great internet awakening, to scientific discoveries and life-saving cures.

The State of Care: Patient Access & Affordability

The Atlantic gathered key perspectives to continue the conversation on what it costs to stay healthy in America today.

Deconstructing the Prescription Drug Supply Chain

PhRMA and POLITICO joined together for a deep-dive conversation on the state of the pharmaceutical supply chain and what can be done to better control costs.

Examining the Pharmaceutical Supply Chain: From Production to Patient

On November 14, 2017, RealClearPolitics—in partnership with The Value Collaborative—brought together a cross-section of experts to examine the biopharmaceutical supply chain.

Vaccines + Immunity: Examining Modern Medicine

How can scientists and researchers effectively engage with the public? Are vaccines a matter of personal choice or public health? What will the future of vaccines look like? The Atlantic gathered stakeholders from public health officials to the medical and scientific community to explore these questions at a forum in Philadelphia.

Future Shapers: A New Era in Cancer Innovation

A series of discussions on the innovations and solutions needed to accelerate efforts towards ending cancer as we know it including conversation with The Honorable Joseph R. Biden Jr.

Research & Hope Awards 2017

These Awards illustrated how biopharmaceutical researchers and others in the innovation ecosystem work together to bring new medical advances to patients.

The Future of Health Care: Unlocking & Supporting Value

The Value Collaborative partnered with Bloomberg to convene CEOs, experts and thought leaders to discuss how stakeholders are working together to unlock and support value in the future of health care.

Precision Medicine Leaders Summit Spotlight: Paying for Personalized Value

The Value Collaborative sponsored a panel of distinguished leaders from the diagnostic, academic and patient communities.

Innovation Pipeline: Examining Modern Medicine

In the third event of the “Examining Modern Medicine” series, The Atlantic will gather stakeholders, original thinkers and trailblazers from the nation’s innovation capital to explore what it means to put the bio into biotech.

Turning the Tide Against Cancer National Conference Spotlight: Partnering to Deliver High-Value Care for Patients

The Turning the Tide Against Cancer National Conference convened leaders from across the oncology community to explore the role of the patient across the continuum of cancer research and care and identify strategies that policymakers might consider to support meaningful patient engagement and deliver value to patients.

The Brain: The Next Frontier

In order to jumpstart a dialogue on the many complex issues impacting the brain, PhRMA is bringing together industry thought leaders, researchers and scientists in Los Angeles for a conversation titled “The Brain: The Next Frontier.”

Prioritizing Patients: A Discussion on Outcomes-Based Care

Sequencing the Genome: Examining Modern Medicine

At a forum in New York, The Atlantic will gather key stakeholders to discuss the future of the genomic era.

Future Shapers: New Cures, New Innovators for a New Era in Mental Health

PhRMA and Axios hosted a discussion on innovation in mental health care with perspectives from experts in technology, biopharmaceutical innovation, community and public advocacy.

A New Negotiation: Moving Payment for Medicines from Volume to Value

Across the health care system there is a movement to better pay for services based on outcomes. Join America's biopharmaceutical companies for a discussion on ways the private prescription medicine marketplace can evolve to produce and reward better value for patients.

Through the Microscope: Examining Modern Medicine

The Pharmaceutical Research and Manufacturers of America (PhRMA) will hold its first national health care dialogue series on February 21, 2017 in Boston, Massachusetts, as part of its new GOBOLDLY campaign and The New Era of Medicine initiative.

Tackling Diabetes: Solutions to a Complex Disease

On December 6th, 2016, PhRMA gathered members of Congress, leaders in the diabetes community, payers, providers and the biopharmaceutical industry in coordination with The Hill publication at The Newseum for a special event titled, “Tackling Diabetes: Solutions to a Complex Disease.”

2016 Congressional Fly-In

PhRMA is bringing 60+ researchers to meet with members of Congress to discuss how they can support development of innovative treatments.

PhRMA Annual Meeting 2016

The Annual Meeting brings together business leaders, policymakers and industry experts to take an in depth look at the state of science and health.